经尿道等离子体电切加剜除术治疗BPH(附230例报告)

Transurethral plasmakinetic vaporization of prostate with enucleation technique in the treatment of benign prostatic hyperplasia(Report of 230 cases)

目的：探讨经尿道等离子体双极电切（TUPKVP）加剜除术治疗BPH的安全性和疗效。方法：回顾性分析经尿道等离子体双极电切加剜除术治疗BPH 230例临床资料。结果：手术操作45～150min，术中平均失血（100±20）ml。切除前列腺重量约12～90g，平均（30±9）g。无经尿道前列腺电切综合征发生。23例（10％）术后膀胱痉挛；2例（0．8％）继发术后出血再次电凝止血。随访2～24个月，IPSS评分平均降至5分。无剩余尿。结论：经尿道等离子体前列腺电切术加剜除术具有安全性高、出血少，手术时间短、并发症少、疗效确切等优点。

Objective：To evaluate the security and effectiveness of transurethral plasmakinetic vaporization of prostate （TUPKVP） with enucleation technique in the treatment of benign prostatic hyperplasia（BPH）. Methods： All of 230 patients admitted to our clinic with symptomatic prostatic obstruction between 2005 and 2007, were included in this study. After surgery, the therapeutic outcome was evaluated using the International Prostate Symptom Score （IPSS）, maximum urinary flow rate （Qmax） and long term complications were surveyed. Result：The operating time was 454150 mins, with mean blood loses of （100±20） ml. The prostate gland excised weight approximately 12490g, average （30±9） g. Twenty-three patients had bladder and two patients （0.8%） had an additional transurethral vaporization of prostate for postoperative heavy bleeding. All patients were followed by 24-24 months. The mean IPSS decreased from 27 to 5 after TUPKVP. Conclusions： TUPKVP with the enucleation technique has good clinical results with high efficacy and safety,and less blood loses in patients with BPH.